Fumaric Acid

Fumaric Acid

SCHEMBL6972364

CCc1cc(Cc2c[nH]cn2)c(CC)s1.O=C(O)C=CC(=O)O

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.31
▸ TMIGD3 P0DMS9 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6972355 1.00 CYP1A2 (0.31) CYP1A2TMIGD3CYP2C9ADORA1MAPK1
Fumaric Acid SCHEMBL6972181 0.80 KDM4E (0.30) —
Fumaric Acid SCHEMBL6972187 0.80 KDM4E (0.30) —
Fumaric Acid SCHEMBL6972062 0.79 MAPT (0.35) —
Fumaric Acid SCHEMBL6972073 0.79 MAPT (0.35) —
Fumaric Acid SCHEMBL8669997 0.77 PLA2G10 (0.30) —
Fumaric Acid SCHEMBL8670002 0.77 PLA2G10 (0.30) —
Fumaric Acid SCHEMBL6971267 0.73 MAPT (0.43) —
Fumaric Acid SCHEMBL6971276 0.73 MAPT (0.43) —
Fumaric Acid SCHEMBL6969275 0.72 KDM4E (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954521-B1 4- (THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING ALPHA2-ADRENOCEPTOR AGONISTIC ACTIVITY ORTHO MCNEIL PHARM INC (US) 2003-05-14 — — EP disclosed
US-5750720-A ALPHA-ADRENORECEPTORS AND CENTRAL NERVOUS SYSTEMS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-05-12 — — US disclosed
Send feedback